Meeder Asset Management »

Janux Therapeutics shares owned by Meeder Asset Management

Quarter-by-quarter ownership of Janux Therapeutics (JANX) shares owned by Meeder Asset Management from 13F filings

Historical chart of Meeder Asset Management investment in Janux Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Janux Therapeutics held by Meeder Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Janux Therapeutics by Meeder Asset Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $159k 3.0k 53.54

More positions owned by Meeder Asset Management

Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Apple (AAPL)
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Ishares Tr Jpmorgan Usd Emg (EMB)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Union Pacific Corporation (UNP)
Ishares Tr 7-10 Yr Trsy Bd (IEF)
Mastercard Incorporated Cl A (MA)
Broadcom (AVGO)
Costco Wholesale Corporation (COST)
Bank of New York Mellon Corporation (BK)
Amazon (AMZN)

View all positions for Meeder Asset Management

Top funds holding Janux Therapeutics

RA Capital Management
FMR
Henderson Group
BlackRock
Paradigm Biocapital Advisors
Adage Capital Partners GP
Vanguard Group
State Street Corporation
OrbiMed Advisors
Point72 Asset Management
Logos Global Management
Geode Capital Management
Woodline Partners
T. Rowe Price Investment Management
Readystate Asset Management

View all funds holding Janux Therapeutics